Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05159596 · ClinicalTrials.gov registry record · NA

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT05159596 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that has completed, run by University of California, Berkeley. The registered enrollment target is 6 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05159596, a NA study of Alzheimer Disease and Mild Cognitive Impairment, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.

Interventions

  • DEVICE In-Home Technology System
  • DEVICE Limited In-Home Technology

Study Locations (1)

California

  • University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2022-09-20
Est. Completion 2023-10-30
Phase NA

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT05159596

The ClinicalTrials.gov registry entry for NCT05159596 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which In-Home Technology System is the first listed.

NCT05159596 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05159596 about?

NCT05159596 is a clinical study titled "In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes". This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.

What is the current status of trial NCT05159596?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-09-20. Estimated completion is 2023-10-30.

What conditions does trial NCT05159596 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Dementia.

What interventions are being tested in trial NCT05159596?

The interventions under investigation include: In-Home Technology System (DEVICE), Limited In-Home Technology (DEVICE).

Who is sponsoring clinical trial NCT05159596?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05159596 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.